Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer
about
Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancerOsimertinib making a breakthrough in lung cancer targeted therapyComparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation.Clinical strategies for acquired epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small-cell lung cancer patients.Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents
P2860
Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Comparison of single-agent che ...... ced non-small-cell lung cancer
@ast
Comparison of single-agent che ...... ced non-small-cell lung cancer
@en
type
label
Comparison of single-agent che ...... ced non-small-cell lung cancer
@ast
Comparison of single-agent che ...... ced non-small-cell lung cancer
@en
prefLabel
Comparison of single-agent che ...... ced non-small-cell lung cancer
@ast
Comparison of single-agent che ...... ced non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
Comparison of single-agent che ...... ced non-small-cell lung cancer
@en
P2093
Qianqian Zhang
Zhehai Wang
P2860
P304
P356
10.2147/OTT.S81837
P407
P577
2015-04-20T00:00:00Z